Researchers at University of California San Diego have revealed promising results from a study evaluating the university’s “Strong Foundations” program, a digitally delivered fall prevention initiative for older adults.
Sorrento goes to China with Covid drug; Vistagen touts early efficacy data on PMDD nasal spray
Sorrento Therapeutics’ oral Mpro inhibitor olgotrelvir has hit the primary endpoint and a key secondary endpoint in a Phase III trial that recruited adults with
September 14, 2023